Related Experiment Video
Updated: May 10, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Lipid profile in antipsychotic drug users: A comparative study
Hamidreza Roohafza1, Azam Khani, Hamid Afshar
1Assistant Professor, Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Conventional antipsychotics significantly increased lipid profiles in schizophrenic patients more than atypical ones. Periodic monitoring of antipsychotic drug effects on lipid profiles is crucial for patient care.
Area of Science:
- Psychiatry
- Pharmacology
- Metabolic Disorders
Background:
- Antipsychotic medications can induce metabolic disturbances in schizophrenic patients, including weight gain, dyslipidemia, and insulin resistance.
- Understanding the differential impact of various antipsychotic classes on metabolic health is critical for patient management.
Purpose of the Study:
- To compare the effects of atypical and conventional antipsychotic drugs on the lipid profiles of schizophrenic patients.
Main Methods:
- 128 schizophrenic patients were divided into two groups: one receiving atypical antipsychotics and the other receiving conventional antipsychotics.
- Fasting blood samples were analyzed for triglyceride, total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and apolipoprotein A and B (Apo B).
- Student's t-test was employed to compare lipid profile parameters between the two groups.
Main Results:
- No significant demographic differences were observed between the atypical and conventional antipsychotic groups.
- Patients on conventional antipsychotics (primarily phenothiazines) showed significantly higher mean levels of TC, LDL, and Apo B compared to those on atypical antipsychotics (clozapine, risperidone, olanzapine).
Conclusions:
- Both atypical and conventional antipsychotics can elevate lipid profiles in schizophrenic patients, with conventional agents showing a more pronounced effect.
- Regular monitoring of lipid profiles is recommended for all schizophrenic patients undergoing antipsychotic therapy to mitigate metabolic risks.
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Antipsychotic Drugs: Typical and Atypical Agents
Psychosis: Goals of Pharmacotherapy
Antidepressant Drugs: MAOIs and Other Agents
Drug Therapy
Antianxiety Medications
Mania and Antimanic Drugs: Overview
